期刊文献+

比索洛尔对慢性心力衰竭患者心率及神经内分泌因子昼夜节律的影响 被引量:21

Chronological effects of bisoprolol on circadian rhythms of heart rate and neurohumoral factors in patients with chronic heart failure
原文传递
导出
摘要 目的探讨比索洛尔对慢性心力衰竭患者心率及神经内分泌因子昼夜节律的影响。方法入选轻到中度慢性收缩性心力衰竭患者(NYHAⅡ-Ⅲ)40例为心力衰竭组,随机分为两亚组(n=20),第1组7:00-8:00服用比索洛尔,第2组19:00-20:00服用比索洛尔;另选正常人20位作为对照组。治疗前和治疗4周后行动态心电图检查,分别于2:00、6:00、10:00、14:00、18:00、22:00共6个时间点测定血浆去甲肾上腺素(NE)、肾上腺素、血管紧张素Ⅱ(AngⅡ)、醛固酮水平。结果慢性心力衰竭患者24h平均心率明显高于正常对照组[(78.7±8.4)比(69.8±9.3)次/min,P<0.05],夜昼心率比值比正常对照组高(0.93比0.86),分别有31例(77.5%)和4例(20.0%)存在非杓型心率。慢性心力衰竭患者各个时间点血浆NE、肾上腺素、AngⅡ、醛固酮水平均比正常对照组高(P<0.01),且昼夜节律消失。相关分析发现无论是对照组还是心力衰竭组,心率与血NE、肾上腺素、AngⅡ水平呈正相关(对照组:分别r=0.6、0.5、0.6;心力衰竭组:分别r=0.7、0.5、0.4,均P<0.05),而与醛固酮水平无相关。干预后,两组心力衰竭患者夜昼心率比值明显降低(第1组:0.89比0.93,第2组:0.88比0.94),第1、2组分别有37.5%(6/16)和66.7%(10/15)的患者由非杓型心率转变为杓型心率。同样也发现两组干预后神经内分泌因子均较治疗前明显降低(P<0.05),但都对昼夜节律没有影响,且两组差异无统计学意义(P>0.05)。结论慢性心力衰竭患者存在24h心率和神经内分泌因子节律异常,不同时间服用比索洛尔均可降低慢性心力衰竭患者心率及神经内分泌因子水平,但均未显著改变昼夜节律。 Objective To investigate chronological effects of bisoprolol on circadian of heart rate (HR) and plasma neurohumoral factors in patients with chronic heart failure (HF). Methods A total of 40 patients with mild and moderate systolic HF (NYHA 11-111 ) were included and randomly divided into group 1 (n= 20, bisoprolol was given between 7:00 and 8:00} and group 2 (n=20, bisoprolol was given between 19:00 and 20:00}. Twenty healthy people were chosen as control group. Ambulatory electrocardiogram was performed in all subjects before and after 4 week treatment. Concurrently, plasma norepinephrine {NE), adrenergic {E), angiotension 111 (Ang II ) and aldosterone ( Aid) levels were detected every a. hours at 2:00 till 22:00. Results The average 24 h HR and night-day HR ratio in chronic HF patients were higher than those in control group [average 24 h HR: (78.7 ± 8.4) vs (69.8 ± 9.3} per minute; ratio: 0.93 vs 0.86, all P〈0. 05-1, The nondipping HR cases were 31 (77. 5%) in HF group while 4 (20.0%) in controls. Increased plasma NE, E, Ang II and Aid levels at all the time points and disordered circadian rhythms could be found in HF patients. Correlation analysis showed that HR was positively correlated with the levels of plasma NE, E and Ang II in both HF and control groups {control group: r=0.6, 0.5, 0.6, HF group: r= 0. 7, 0. 5, 0.4; all P〈:0. 05 ), but it was not obviously related to Ald. Night-day ratio of HR in the two HF groups was decreased significantly after intervention (group 1 : 0. 89 vs 0. 93; group 2: 0. 88 vs 0. 94). The cases of HR circadian variation from nondipper to dipper were 37.5%(6/16) in group 1 and 66.7% (10/15) in group 2. After the intervention, the levels of neurohumoral factors of the two groups were lowered notably (P〈0.05),meanwhile, circadian rhythms showed no significant changes as compared with those before treatment. And there was no statistically significant difference between the two HF groups (P〉0.05). Conclusions Circadian rhythms of HR and neurohumoral factors are abnormal in patients with chronic HF. Bisoprolol intervention at various time can lower HR and the levels of neurohumoral factors in chronic HF patients, but it can not obviously affect the circadian rhythms.
出处 《中华高血压杂志》 CAS CSCD 北大核心 2013年第3期232-237,共6页 Chinese Journal of Hypertension
基金 福建省科技厅重点项目(2010Y0021)
关键词 慢性心力衰竭 比索洛尔 心率 神经内分泌因子 Chronic heart failure Bisoprolol Heart rate Neurohumoral factors
  • 相关文献

参考文献21

  • 1Ben-Dov IZ, Kark JD, Ben-Ishay D, et al. Blunted heart rate dip during sleep and all-cause mortality[J]. Arch Intern Med, 2007, 167(19) :2116-2121.
  • 2Verdecchia P, Schillaci G, Borgioni C, et al. Adverse prognostic value olr a blunted circadian rhythm of heart rate in essential hy- pertension[J]. J Hypertens, 1998,16(9) : 1335-1343.
  • 3Hozawa A, Inoue R, Ohkubo T, et al. Predictive value of ambu- latory heart rate in the Japanese general population: the Ohasama study[J]. J Hypertens,2008,26(8) : 1571-1576.
  • 4Palatini P, Thijs L, Staessen JA, et al. Systolic hypertension in Europe (Syst-Eur) trial investigators. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension[J]. Arch Intern Med, 2002,162 (20) : 2313- 2321.
  • 5Sega R, Facehetti R, Bombelli M. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the pressioni arte- riose monitorale e loro associazioni (PAMELA) study [ J ]. Circulation, 2005,111 ( 14 ) : 1777-1783.
  • 6van de Borne Philippe, Abramowicz M, Degre BS, et al. Belgium effects of chronic congestive heart failure on 24-hour blood pres- sure and heart rate patterns: a hemodynamic approach[J]. Am Heart J,1992,123(4Ptl) :998-1004.
  • 7Carson PA, OConnor CM, Miller AB, et al. Circadian rhythmand sudden death in heart failure: results from prospective ran- domized amlodipine survival trial[J]. J Am Coil Cardiol, 2000,36 (2) :541-546.
  • 8Klerman EB. Clinical aspects of human circadian rhythms[J]. Biol Rhythms, 2005,20(4) :375-386.
  • 9Floras JS. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model[J]. J Am Coll Cardiol, 2009,54 (5) : 375-385.
  • 10Dube P, Weber KT. Congestive heart failure: pathophysiologic consequences of neurohormonal activation and the potential for re- covery: part Ⅱ[J].AmJ MedSci,2011,342(6):503-506.

二级参考文献16

  • 1[1]Portaluppi F,Smolensky MH,editors.Time-Dependent structure and control of arterial blood pressure[M].New York (New York):New York Academy of Sciences,1996.
  • 2[2]Hermida RC,Ayala DE,Fernandez JR,et al.Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis[J].Chronobiol Int,2002,19:461-481.
  • 3[3]Higashi Y,Nakagawa K,Kimura M,et al.Circadian variation of blood pressure and endothelial function in patients with essential hypertension:a comparison of dippers and non-dippers[J].J Am Coll Cardiol,2002,40:2039-2043.
  • 4[4]Dolan E,Stanton A,Thijs L,et al.Superiority of ambulatory over clinic blood pressure measurement in predicting mortality:the Dublin outcome study[J].Hypertension,2005,46:156-161.
  • 5[5]Hermida RC,Calvo C,Ayala DE,et al.Seasonal variation of fibrinogen in dipper and nondipper hypertensive patients[J].Circulation,2003,108:1101-1106.
  • 6[6]Kikuya M,Ohkubo T,Asayama K,et al.Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality:the ohasama study[J].Hypertension,2005,45:240-245.
  • 7[7]Smolensky MH,Hermida RC,Portaluppi F,et al.Chronotherapy of hypertension[M]//In:Oparil S,Weber MA,editors.Hypertension:A Companion to Brenner and rector's the Kidney.2nd ed.Philadelphia (Pennsylvania):Elsevier Saunders; 2005:530-542.
  • 8[8]Umeda T,Naomi S,Iwaoka T,et al.Timing for administration of an antihypertensive drug in the treatment of essential hypertension[J].Hypertension,1994,23(Suppl 1):1211-1214.
  • 9[9]Hermida RC,Calvo C,Ayala DE,et al.Administration time-dependent effects of nifedipine GITS on ambulatory blood pressure in patients with essential hypertension[abstract][J].Am J Hypertens,2005,18(5 Pt 2):63A.
  • 10[10]Svensson P,de Faire U,Sleight P,et al.Comparative effects of ramipril on ambulatory and office blood pressures:a HOPE substudy[J].Hypertension,2001,38:E28-E32.

共引文献20

同被引文献174

  • 1迟小伟,刘杰.hs-CRP、IL-6、TNF-α在心血管疾病中的意义[J].医学检验与临床,2008,20(3):50-51. 被引量:10
  • 2谷春华,吴以岭,田书彦,高学东,齐晓琳,贾振华,杨立波,李云鹏,徐贵成.参松养心胶囊对冠心病室性早搏疗效及心脏自主神经功能的影响[J].中国中西医结合杂志,2005,25(9):783-786. 被引量:98
  • 3宫军芳,宫伟民,汤建民.比索洛尔对老年高血压伴糖尿病和慢性阻塞性肺疾病的疗效观察[J].中国实用神经疾病杂志,2006,9(4):130-131. 被引量:6
  • 4杨顺昱,麦炜颐.卡维地洛与比索洛尔治疗慢性心力衰竭的疗效比较研究[J].中国实用内科杂志,2007,27(18):1451-1453. 被引量:16
  • 5闭清.慢性心力衰竭患者血清甲状腺激素水平的变化及其临床意义[J].实用心脑肺血管病杂志,2013,21(5):134-135.
  • 6Papanikolaou J, Tsolaki V, Makris D, et al. Early levosimendan administration may improve outcome in patients with subarach- noid hemorrhage complicated by acute heart failure [J]. Int J Cardiol, 2014, 176(3).-1435-1437.
  • 7Cullen L,Than M,Peacock WF. Undetectable hs-cTnT in the e- mergency department and risk of myocardial infarction [J]. J Am Coll Cardiol, 2014, 64(6) ;632-633.
  • 8Chon H,Lee S,Yoon SY,et al. SERS-based competitive immu- noassay of troponin I and CK-MB markers for early diagnosis of acutemyocardial infaretion[-J;. Chem Commun (Camb), 2014, 50(9) : 1058-1060.
  • 9Rossignol P, Zannad F, Pitt B. Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition inheart failure patients with reduced ejection fraction: lessons from randomized controlled trials and registries[J]. Int J Cardi- ol, 2014, 177(3);731-733.
  • 10Rengo G, Pagano G, Parisi V, et al. Changes of plasma norepi- nephrine and serum N-terminal pro-brain natriuretic peptide af- ter exereise training predict survival in patients with heart fail- ure[J]. Int J Cardiol, 2014,171 (3) : 384-389.

引证文献21

二级引证文献204

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部